Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Interstitial granulomatous dermatitis with arthritis is a rare rheumatologic disease characterized by the occurrence of inflammatory arthritis in association with large, erythematous, symmetrical cutaneous lesions (ranging from typical, but infrequent, cord-like lesions on the flanks to more common violaceous plaques on the trunk and limbs) featuring a typical histologic infiltrate mainly constituted of histiocytes.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for interstitial granulomatous dermatitis with arthritis.
3 publications have been identified in PubMed for interstitial granulomatous dermatitis with arthritis. Research spans Case Report / Case Series (67%) and Epidemiology / Natural History (33%).
Deva M (2026). [PMID: 42016781](https://pubmed.ncbi.nlm.nih.gov/42016781/). *JAAD Case Rep*. [Case Report / Case Series]
Shi X (2025). [PMID: 40350497](https://pubmed.ncbi.nlm.nih.gov/40350497/). *BMC Pediatr*. [Epidemiology / Natural History]
Chaurasia P (2024). [PMID: 39130974](https://pubmed.ncbi.nlm.nih.gov/39130974/). *Cureus*. [Case Report / Case Series]
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 5:37 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning interstitial granulomatous dermatitis with arthritis
Updated Sep 17, 2026
A systematic review and expert opinion on treatment strategies for interstitial granulomatous dermatitis has been published, providing insights into effective management approaches. This review consolidates current knowledge and expert recommendations for clinicians treating this rare skin condition.
A case report highlights granulomatous interstitial nephritis with perivascular involvement in a patient with carbamazepine-induced DRESS syndrome. This finding contributes to the understanding of renal complications associated with drug reactions.